160 related articles for article (PubMed ID: 10191201)
1. Multiple sequence-reactive antibodies induced by a single peptide immunization with hypervariable region 1 of hepatitis C virus.
Zhou YH; Moriyama M; Esumi M
Virology; 1999 Apr; 256(2):360-70. PubMed ID: 10191201
[TBL] [Abstract][Full Text] [Related]
2. Murine antibodies against E2 and hypervariable region 1 cross-reactively capture hepatitis C virus.
Esumi M; Ahmed M; Zhou YH; Takahashi H; Shikata T
Virology; 1998 Nov; 251(1):158-64. PubMed ID: 9813211
[TBL] [Abstract][Full Text] [Related]
3. Broadly cross-reactive, high-affinity antibody to hypervariable region 1 of the hepatitis C virus in rabbits.
Shang D; Zhai W; Allain JP
Virology; 1999 Jun; 258(2):396-405. PubMed ID: 10366577
[TBL] [Abstract][Full Text] [Related]
4. Towards a solution for hepatitis C virus hypervariability: mimotopes of the hypervariable region 1 can induce antibodies cross-reacting with a large number of viral variants.
Puntoriero G; Meola A; Lahm A; Zucchelli S; Ercole BB; Tafi R; Pezzanera M; Mondelli MU; Cortese R; Tramontano A; Galfre' G; Nicosia A
EMBO J; 1998 Jul; 17(13):3521-33. PubMed ID: 9649423
[TBL] [Abstract][Full Text] [Related]
5. Antibody responses to hepatitis C virus hypervariable region 1: evidence for cross-reactivity and immune-mediated sequence variation.
Mondelli MU; Cerino A; Lisa A; Brambilla S; Segagni L; Cividini A; Bissolati M; Missale G; Bellati G; Meola A; Bruniercole B; Nicosia A; Galfrè G; Silini E
Hepatology; 1999 Aug; 30(2):537-45. PubMed ID: 10421665
[TBL] [Abstract][Full Text] [Related]
6. Mimotopes of the hepatitis C virus hypervariable region 1, but not the natural sequences, induce cross-reactive antibody response by genetic immunization.
Zucchelli S; Roccasecca R; Meola A; Ercole BB; Tafi R; Dubuisson J; Galfré G; Cortese R; Nicosia A
Hepatology; 2001 Mar; 33(3):692-703. PubMed ID: 11230750
[TBL] [Abstract][Full Text] [Related]
7. The hypervariable region 1 protein of hepatitis C virus broadly reactive with sera of patients with chronic hepatitis C has a similar amino acid sequence with the consensus sequence.
Watanabe K; Yoshioka K; Ito H; Ishigami M; Takagi K; Utsunomiya S; Kobayashi M; Kishimoto H; Yano M; Kakumu S
Virology; 1999 Nov; 264(1):153-8. PubMed ID: 10544140
[TBL] [Abstract][Full Text] [Related]
8. Broadly cross-reactive mimotope of hypervariable region 1 of hepatitis C virus derived from DNA shuffling and screened by phage display library.
Zhang XX; Deng Q; Zhang SY; Liu J; Cai Q; Lu ZM; Wang Y
J Med Virol; 2003 Dec; 71(4):511-7. PubMed ID: 14556263
[TBL] [Abstract][Full Text] [Related]
9. B-cell epitopes in hypervariable region 1 of hepatitis C virus obtained from patients with chronic persistent hepatitis.
Nakamoto Y; Kaneko S; Ohno H; Honda M; Unoura M; Murakami S; Kobayashi K
J Med Virol; 1996 Sep; 50(1):35-41. PubMed ID: 8890039
[TBL] [Abstract][Full Text] [Related]
10. Antibodies directed to envelope proteins of hepatitis C virus outside of hypervariable region 1.
Lechner S; Rispeter K; Meisel H; Kraas W; Jung G; Roggendorf M; Zibert A
Virology; 1998 Apr; 243(2):313-21. PubMed ID: 9568031
[TBL] [Abstract][Full Text] [Related]
11. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.
Vietheer PT; Boo I; Drummer HE; Netter HJ
Antivir Ther; 2007; 12(4):477-87. PubMed ID: 17668556
[TBL] [Abstract][Full Text] [Related]
12. T cell recognition of hypervariable region-1 from hepatitis C virus envelope protein with multiple class II MHC molecules in mice and humans: preferential help for induction of antibodies to the hypervariable region.
Shirai M; Arichi T; Chen M; Masaki T; Nishioka M; Ikeda K; Takahashi H; Enomoto N; Saito T; Major ME; Nakazawa T; Akatsuka T; Feinstone SM; Berzofsky JA
J Immunol; 1999 Jan; 162(1):568-76. PubMed ID: 9886434
[TBL] [Abstract][Full Text] [Related]
13. Sequences in the hypervariable region 1 of hepatitis C virus show only minimal variability in the presence of antibodies against hypervariable region 1 during acute infection in chimpanzees.
Zhou YH; Sugitani M; Esumi M
Arch Virol; 2002 Oct; 147(10):1955-62. PubMed ID: 12376756
[TBL] [Abstract][Full Text] [Related]
14. In vivo and in vitro evidence that cross-reactive antibodies to C-terminus of hypervariable region 1 do not neutralize heterologous hepatitis C virus.
Esumi M; Zhou YH; Tanoue T; Tomoguri T; Hayasaka I
Vaccine; 2002 Aug; 20(25-26):3095-103. PubMed ID: 12163260
[TBL] [Abstract][Full Text] [Related]
15. Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment.
Zibert A; Schreier E; Roggendorf M
Virology; 1995 Apr; 208(2):653-61. PubMed ID: 7538251
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies to the hypervariable region 1 of hepatitis C virus capture virus and inhibit virus adsorption to susceptible cells in vitro.
Zhou YH; Shimizu YK; Esumi M
Virology; 2000 Apr; 269(2):276-83. PubMed ID: 10753706
[TBL] [Abstract][Full Text] [Related]
17. Broadly reactive antibodies to hypervariable region 1 in hepatitis C virus-infected patient sera: relation to viral loads and response to interferon.
Hattori M; Yoshioka K; Aiyama T; Iwata K; Terazawa Y; Ishigami M; Yano M; Kakumu S
Hepatology; 1998 Jun; 27(6):1703-10. PubMed ID: 9620346
[TBL] [Abstract][Full Text] [Related]
18. Role of the E2 Hypervariable Region (HVR1) in the Immunogenicity of a Recombinant Hepatitis C Virus Vaccine.
Law JLM; Logan M; Wong J; Kundu J; Hockman D; Landi A; Chen C; Crawford K; Wininger M; Johnson J; Mesa Prince C; Dudek E; Mehta N; Tyrrell DL; Houghton M
J Virol; 2018 Jun; 92(11):. PubMed ID: 29540595
[TBL] [Abstract][Full Text] [Related]
19. Genotype dependence of peptide-based immunoassays for the detection of HCV core antibodies.
Muerhoff AS; Gutierrez R; Kyrk C; Leary T; Schlauder G; Dawson G; Desai SM
J Med Virol; 2008 Mar; 80(3):411-8. PubMed ID: 18205228
[TBL] [Abstract][Full Text] [Related]
20. Immunoreactivity of HCV/HBV epitopes displayed in an epitope-presenting system.
Chen Y; Xiong X; Liu X; Li J; Wen Y; Chen Y; Dai Q; Cao Z; Yu W
Mol Immunol; 2006 Feb; 43(5):436-42. PubMed ID: 16337486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
